Basic Information
| LncRNA/CircRNA Name | TINCR |
| Synonyms | TINCR, LINC00036, NCRNA00036, PLAC2, onco-lncRNA-16 |
| Region | GRCh38_19:5558167-5578349 |
| Ensemble | ENSG00000223573 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR |
| Sample | EOC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | TINCR expression was higher in EOC tissues and cell lines compared with normal cells. |
| Pubmed ID | 31545411 |
| Year | 2019 |
| Title | Silencing the long noncoding RNA, TINCR, a molecular sponge of miR-335,inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression. |
External Links
| Links for TINCR | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |